CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88,938 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04407936
NCT04407936N/ACompleted

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention

Guangdong Provincial People's Hospital·observational·Posted May 29, 2020·Updated Sep 14, 2021

In Brief

An observational study for Cardio-Renal Syndrome and 4 related conditions. Completed, enrolled 88,938 participants across 1 site.

Detailed Summary

As a single center, retrospective observation study in Guangdong Institute of Cardiovascular Diseases, this study included the main study population of patients who underwent coronary angiography and / or coronary intervention from January 2007 to Decemeber 2018. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient recorder system. All-cause death information was obtained from the Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 29, 2020
Enrollment StartJun 1, 2007
Primary CompletionDec 31, 2018
Study CompletionMar 10, 2020
TodayJul 2, 2026
Enrollment to primary: 11.6 yearsPosted 6.1 years ago